Ryan Mcnabb, PA

NPI: 1184823064
Total Payments
$16.03
2021 Payments
$16.03
Companies
1
Transactions
3
Medicare Patients
1,992
Medicare Billing
$81,929

Payment Breakdown by Category

Food & Beverage$16.03 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $16.03 3 100.0%

Top Paying Companies

Company Total Records Latest Year
Genentech USA, Inc. $16.03 3 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2021 $16.03 3 Genentech USA, Inc. ($16.03)

All Payment Transactions

3 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
12/03/2021 Genentech USA, Inc. Xofluza (Drug) Food and Beverage In-kind items and services $5.31 General
Category: Virology & Specialty Care
11/23/2021 Genentech USA, Inc. Xofluza (Drug) Food and Beverage In-kind items and services $5.03 General
Category: Virology & Specialty Care
11/17/2021 Genentech USA, Inc. Xofluza (Drug) Food and Beverage In-kind items and services $5.69 General
Category: Virology & Specialty Care

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 6 180 244 $13,395 $4,918
2022 17 635 900 $83,043 $26,289
2021 16 596 770 $81,840 $28,713
2020 14 581 910 $81,255 $22,009
Total Patients
1,992
Total Services
2,824
Medicare Billing
$81,929
Procedure Codes
53

All Medicare Procedures & Services

53 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
87804 Detection test by immunoassay with direct visual observation for influenza virus Office 2023 50 108 $4,389 $1,752 39.9%
87811 Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) Office 2023 42 44 $4,868 $1,744 35.8%
87426 Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus Office 2023 22 22 $1,999 $761.64 38.1%
87880 Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) Office 2023 26 27 $1,107 $437.40 39.5%
71046 X-ray of chest, 2 views Office 2023 13 14 $727.16 $159.96 22.0%
81003 Automated urinalysis test Office 2023 27 29 $305.00 $63.80 20.9%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 116 130 $17,740 $5,857 33.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 75 83 $16,836 $5,351 31.8%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 37 37 $11,463 $3,741 32.6%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 60 60 $12,132 $3,287 27.1%
87811 Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) Office 2022 72 73 $11,023 $2,995 27.2%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2022 12 12 $4,677 $2,046 43.7%
87804 Detection test by immunoassay with direct visual observation for influenza virus Office 2022 28 56 $1,745 $918.12 52.6%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2022 17 19 $1,547 $793.54 51.3%
71046 X-ray of chest, 2 views Office 2022 29 31 $1,586 $506.55 31.9%
87880 Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) Office 2022 15 15 $467.40 $244.78 52.4%
96372 Injection of drug or substance under skin or into muscle Office 2022 32 33 $1,536 $219.24 14.3%
36415 Insertion of needle into vein for collection of blood sample Office 2022 41 49 $294.00 $145.47 49.5%
81003 Automated urinalysis test Office 2022 44 47 $705.00 $104.17 14.8%
94640 Inhalation treatment for airway obstruction or sputum production Office 2022 12 12 $397.44 $53.66 13.5%
J0696 Injection, ceftriaxone sodium, per 250 mg Office 2022 11 44 $440.00 $15.85 3.6%
J1100 Injection, dexamethasone sodium phosphate, 1 mg Office 2022 21 168 $268.80 $10.06 3.7%
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg Office 2022 13 31 $186.00 $0.73 0.4%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 119 142 $19,377 $7,348 37.9%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 79 89 $18,053 $6,892 38.2%

About Ryan Mcnabb, PA

Ryan Mcnabb, PA is a Physician Assistant healthcare provider based in Athens, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/12/2007. The National Provider Identifier (NPI) number assigned to this provider is 1184823064.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ryan Mcnabb, PA has received a total of $16.03 in payments from pharmaceutical and medical device companies, with $16.03 received in 2021. These payments were reported across 3 transactions from 1 company. The most common payment nature is "Food and Beverage" ($16.03).

As a Medicare-enrolled provider, Mcnabb has provided services to 1,992 Medicare beneficiaries, totaling 2,824 services with total Medicare billing of $81,929. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.

Practice Information

  • Specialty Physician Assistant
  • Location Athens, TN
  • Active Since 07/12/2007
  • Last Updated 11/19/2007
  • Taxonomy Code 363A00000X
  • Entity Type Individual
  • NPI Number 1184823064

Products in Payments

  • Xofluza (Drug) $16.03

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Physician Assistant Doctors in Athens